Floating prioritized subset analysis: A powerful method to detect differentially expressed genes

Computational Statistics and Data Analysis

Volumn 55, Issue 1, 2011, Pages 903-913

  Lin, Wan Yu ^a   Lee, Wen Chung ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

False discovery rate; Gene expression; Microarray; Multiple comparisons; Multiple hypothesis testing; Simultaneous inference

Indexed keywords

BIOASSAY; DISEASES; GENES; MICROARRAYS; SET THEORY; STATISTICAL TESTS;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOID LEUKEMIA; DIFFERENTIALLY EXPRESSED GENE; FALSE DISCOVERY RATE; GENE EXPRESSION DATA ANALYSIS; MULTIPLE COMPARISON; MULTIPLE HYPOTHESIS TESTING; SIMULTANEOUS INFERENCE;

GENE EXPRESSION;

EID: 77958041525     PISSN: 01679473     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.csda.2010.07.023     Document Type: Article

References (63)

1. Alon, U., Barkai, N., Notterman, D.A., Gish, K., Ybarra, S., Mack, D., Levine, A.J., 1999. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 96, 6745-6750.
2. Antras, J., Lasnier, F., Pairault, J., 1991. Adipsin gene expression in 3T3-F442A adipocytes is posttranscriptionally down-regulated by retinoic acid. J. Biol. Chem. 266, 1157-1161.
3. Barnard, G.F., Mori, M., Staniunas, R.J., Begum, N.A., Bao, S., Puder, M., Cobb, J., Redman, K.L., Steele Jr., G.D., Chen, L.B., 1995. Ubiquitin fusion proteins are overexpressed in colon cancer but not in gastric cancer. Biochim. Biophys. Acta 1272, 147-153.
4. Benjamini, Y., Hochberg, Y., 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57, 289-300.
5. Benjamini, Y., Hochberg, Y., 1997. Multiple hypotheses testing with weights. Scand. J. Stat. 24, 407-418.
6. Blaser, S., Jersch, K., Hainmann, I., Wunderle, D., Zgaga-Griesz, A., Busse, A., Zieger, B., 2002. Human septin-septin interaction: CDCrel-1 partners with KIAA0202. FEBS Lett. 519, 169-172.
7. Bolmont, C., Lilienbaum, A., Paulin, D., Grimaud, J.A., 1990. Expression of desmin gene in skeletal and smooth muscle by in situ hybridization using a human desmin gene probe. J. Submicrosc. Cytol. Pathol. 22, 117-122.
8. Burdick, M.M., Konstantopoulos, K., 2004. Platelet-induced enhancement of LS174T colon carcinoma and THP-1 monocytoid cell adhesion to vascular endothelium under flow. Am. J. Physiol. Cell. Physiol. 287, C539-C547.
9. Cheng, C., Pounds, S.B., Boyett, J.M., Pei, D., Kuo, M.L., Roussel, M.F., 2004. Statistical significance threshold criteria for analysis of microarray gene expression data. Stat. Appl. Genet. Mol. Biol. 3, Article 36.
10. Chertov, O., Michiel, D.F., Xu, L., Wang, J.M., Tani, K., Murphy, W.J., Longo, D.L., Taub, D.D., Oppenheim, J.J., 1996. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T -cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J. Biol. Chem. 271, 2935-2940.
11. Dickstein, J.I., Davis, E.M., Roulston, D., 2001. Localization of the chromosome 22 breakpoints in two cases of acute megakaryoblastic leukemia with t(1;22)(p13;q13). Cancer Genet. Cytogent. 129, 150-154.
12. Domer, P.H., Fakharzadeh, S.S., Chen, C.S., Jockel, J., Johansen, L., Silverman, G.A., Kersey, J.H., Korsmeyer, S.J., 1993. Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. Proc. Natl. Acad. Sci. USA 90, 7884-7888.
13. Easwaran, V., Song, V., Polakis, P., Byers, S., 1999. The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of beta-catenin-lymphocyte enhancer-binding factor signaling. J. Biol. Chem. 274, 16641-16645.
14. Genovese, C., Roeder, K., Wasserman, L., 2006. False discovery control with P-value weighting. Biometrika 93, 509-524.
15. Golub, T.R., Slonim, D.K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J.P., Coller, H., Loh, M.L., Downing, J.R., Caligiuri, M.A., Bloomfield, C.D., Lander, E.S., 1999. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531-537.
16. Greenwood, C.M., Rangrej, J., Sun, L., 2007. Optimal selection of markers for validation or replication from genome-wide association studies. Genet. Epidemiol. 31, 396-407.
17. Guzman, M.L., Neering, S.J., Upchurch, D., Grimes, B., Howard, D.S., Rizzieri, D.A., Luger, S.M., Jordan, C.T., 2001. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood 98, 2301-2307.
18. Handen, J.S., Rosenberg, H.F., 1997. Intronic enhancer activity of the eosinophil-derived neurotoxin (RNS2) and eosinophil cationic protein (RNS3) genes is mediated by an NFAT-1 consensus binding sequence. J. Biol. Chem. 272, 1665-1669.
19. Hayakawa, F., Towatari, M., Iida, H., Wakao, H., Kiyoi, H., Naoe, T., Saito, H., 1998. Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia. Br. J. Haematol. 101, 521-528.
20. Hung, H.M., O'Neill, R.T., Bauer, P., Kohne, K., 1997. The behavior of the P-value when the alternative hypothesis is true. Biometrics 53, 11-22.
21. Janssen, H., Marynen, P., 2006. Interaction partners for human ZNF384/CIZ/NMP4-zyxin as a mediator for p130CAS signaling? Exp. Cell Res. 312, 1194-1204.
22. Jung, S.H., 2005. Sample size for FDR-control in microarray data analysis. Bioinformatics 21, 3097-3104.
23. Klein, S.C., Kube, D., Abts, H., Diehl, V., Tesch, H., 1996. Promotion of IL8, IL10, TNF alpha and TNF beta production by EBV infection. Leuk. Res. 20, 633-636.
24. Kohka, H., Yoshino, T., Iwagaki, H., Sakuma, I., Tanimoto, T., Matsuo, Y., Kurimoto, M., Orita, K., Akagi, T., Tanaka, N., 1998. Interleukin-18/ interferon-gamma- inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells. J. Leukocyte Biol. 64, 519-527.
25. Korn, E.L., Li, M.C., McShane, L.M., Simon, R., 2007. An investigation of two multivariate permutation methods for controlling the false discovery proportion. Stat. Med. 26, 4428-4440.
26. Korn, E.L., Troendle, J.F., McShane, L.M., Simon, R., 2004. Controlling the number of false discoveries: application to high-dimensional genomic data. J. Statist. Plann. Inference 124, 379-398.
27. Kowalski, J., Denhardt, D.T., 1989. Regulation of the mRNA for monocyte-derived neutrophil-activating peptide in differentiating HL60 promyelocytes. Mol. Cell Biol. 9, 1946-1957.
28. Kuo, M.L., Huang, T.S., Lin, J.K., 1995. Preferential requirement for protein tyrosine phosphatase activity in the 12-O-tetradecanoylphorbol-13- acetate- induced differentiation of human colon cancer cells. Biochem. Pharmacol. 50, 1217-1222.
29. Lee, D.H., Anderson, K.E., Harnack, L.J., Folsom, A.R., Jacobs Jr., D.R., 2004. Heme iron, zinc, alcohol consumption, and colon cancer: iowa women's health study. J. Natl. Cancer Inst. 96, 403-407.
30. Lee, R.A., Kim, H.A., Kang, B.Y., Kim, K.H., 2006. Hemoglobin induces colon cancer cell proliferation by release of reactive oxygen species. World J. Gastroenterol 12, 5644-5650.
31. Lee, W.S., Seo, G., Shin, H.J., Yun, S.H., Yun, H., Choi, N., Lee, J., Son, D., Cho, J., Kim, J., Cho, Y.B., Chun, H.K., Lee, W.Y., 2008. Identification of differentially expressed genes in microsatellite stable HNPCC and sporadic colon cancer. J. Surg. Res. 144, 29-35.
32. Levine, R.L., Wadleigh, M., Sternberg, D.W., Wlodarska, I., Galinsky, I., Stone, R.M., DeAngelo, D.J., Gilliland, D.G., Cools, J., 2005. KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32). Leukemia 19, 27-30.
33. Li, C., Li, M., Lange, E.M., Watanabe, R.M., 2008. Prioritized subset analysis: improving power in genome-wide association studies. Hum. Hered. 65, 129-141.
34. Lin, W.-Y., Lee, W.-C., 2010. Incorporating prior knowledge to facilitate discoveries in a genome-wide association study on age-related macular degeneration. BMC Res. Notes 3, 26.
35. Melhem, R., Hailat, N., Kuick, R., Hanash, S.M., 1997. Quantitative analysis of Op18 phosphorylation in childhood acute leukemia. Leukemia 11, 1690-1695.
36. Melki, J.R., Vincent, P.C., Clark, S.J., 1999. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res. 59, 3730-3740.
37. Mori, M., Barnard, G.F., Staniunas, R.J., Jessup, J.M., Steele Jr., G.D., Chen, L.B., 1993. Prothymosin-alpha mRNA expression correlates with that of c-mycin human colon cancer. Oncogene 8, 2821-2826.
38. Mullighan, C.G., Downing, J.R., 2009. Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions. Leukemia 23, 1209-1218.
39. Narisawa, T., Fukaura, Y., Terada, K., Umezawa, A., Tanida, N., Yazawa, K., Ishikawa, C., 1994. Prevention of 1, 2-dimethylhydrazine-induced colon tumorigenesis by HMG-CoA reductase inhibitors, pravastatin and simvastatin, in ICR mice. Carcinogenesis 15, 2045-2048.
40. Oura, T., Matsui, S., Kawakami, K., 2009. Sample size calculations for controlling the distribution of false discovery proportion in microarray experiments. Biostatistics 10, 694-705.
41. Pigazzi, M., Manara, E., Baron, E., Basso, G., 2008. ICER expression inhibits leukemia phenotype and controls tumor progression. Leukemia 22, 2217-2225.
42. Qiu, X., Yakovlev, A., 2006. Some comments on instability of false discovery rate estimation. J. Bioinform. Comput. Biol. 4, 1057-1068.
43. Rhee, K., Bresnahan, W., Hirai, A., Hirai, M., Thompson, E.A., 1995. c-Myc and cyclin D3 (CcnD3) genes are independent targets for glucocorticoid inhibition of lymphoid cell proliferation. Cancer Res. 55, 4188-4195.
44. Roeder, K., Bacanu, S.A., Wasserman, L., Devlin, B., 2006. Using linkage genome scans to improve power of association in genome scans. Am. J. Hum. Genet. 78, 243-252.
45. Rothman, T.P., Chen, J., Howard, M.J., Costantini, F., Schuchardt, A., Pachnis, V., Gershon, M.D., 1996. Increased expression of laminin-1 and collagen (IV) subunits in the aganglionic bowel of ls/ls, but not c-ret -/- mice. Dev. Biol. 178, 498-513.
46. Schafer, H., Trauzold, A., Siegel, E.G., Folsch, U.R., Schmidt, W.E., 1996. PRG1: a novel early-response gene transcriptionally induced by pituitary adenylate cyclase activating polypeptide in a pancreatic carcinoma cell line. Cancer Res. 56, 2641-2648.
47. Shimada, H., Ichikawa, H., Ohki, M., 2002. Potential involvement of the AML1-MTG8 fusion protein in the granulocytic maturation characteristic of the t(8;21) acute myelogenous leukemia revealed by microarray analysis. Leukemia 16, 874-885.
48. Silver, A., Moody, J., Dunford, R., Clark, D., Ganz, S., Bulman, R., Bouffler, S., Finnon, P., Meijne, E., Huiskamp, R., Cox, R., 1999. Molecular mapping of chromosome 2 deletions in murine radiation-induced AML localizes a putative tumor suppressor gene to a 1.0 cm region homologous to human chromosome segment 11p11-12. Genes Chromosome. Cancer 24, 95-104.
49. Sinicrope, F.A., Hart, J., Michelassi, F., Lee, J.J., 1995. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma. Clin. Cancer Res. 1, 1103-1110.
50. Song, S., Byrd, J.C., Mazurek, N., Liu, K., Koo, J.S., Bresalier, R.S., 2005. Galectin-3 modulates MUC2 mucin expression in human colon cancer cells at the level of transcription via AP-1 activation. Gastroenterology 129, 1581-1591.
51. Storey, J.D., 2002. A direct approach to false discovery rates. J. R. Stat. Soc. Ser. B 64, 479-498.
52. Storey, J.D., Tibshirani, R., 2003. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA 100, 9440-9445.
53. Strimmer, K., 2008a. Fdrtool: a versatile R package for estimating local and tail area-based false discovery rates. Bioinformatics 24, 1461-1462.
54. Strimmer, K., 2008b. A unified approach to false discovery rate estimation. BMC Bioinform. 9, 303.
55. Sun, L., Craiu, R.V., Paterson, A.D., Bull, S.B., 2006. Stratified false discovery control for large-scale hypothesis testing with application to genome-wide association studies. Genet. Epidemiol. 30, 519-530.
56. Towatari, M., Iida, H., Tanimoto, M., Iwata, H., Hamaguchi, M., Saito, H., 1997. Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells. Leukemia 11, 479-484.
57. Tozzi, M.G., Camici, M., Pesi, R., Allegrini, S., Sgarrella, F., Ipata, P.L., 1991. Nucleoside phosphotransferase activity of human colon carcinoma cytosolic 50-nucleotidase. Arch. Biochem. Biophys. 291, 212-217.
58. Wakioka, T., Sasaki, A., Mitsui, K., Yokouchi, M., Inoue, A., Komiya, S., Yoshimura, A., 1999. APS, an adaptor protein containing Pleckstrin Homology (PH) and Src homology-2 (SH2) domains inhibits the JAK-STAT pathway in collaboration with c-Cbl. Leukemia 13, 760-767.
59. Whittemore, A., 2007. A Bayesian false discovery rate for multiple testing. J. Appl. Stat. 34, 1-9.
60. Wu, B.Y., Hanley, E.W., Turka, L.A., Nabel, G.J., 1992. Isolation of a cDNA clone encoding a zinc finger protein highly expressed in T -leukemia lines. Blood 80, 2571-2576.
61. Xie, Y., Pan, W., Khodursky, A.B., 2005. A note on using permutation-based false discovery rate estimates to compare different analysis methods for microarray data. Bioinformatics 21, 4280-4288.
62. Yasumoto, K., Shibahara, S., 1997. Molecular cloning of cDNA encoding a human TFEC isoform, a newly identified transcriptional regulator. Biochim. Biophys. Acta 1353, 23-31.
63. Yoo, B.C., Jeon, E., Hong, S.H., Shin, Y.K., Chang, H.J., Park, J.G., 2004. Metabotropic glutamate receptor 4-mediated 5-Fluorouracil resistance in a human colon cancer cell line. Clin. Cancer Res. 10, 4176-4184.